Abstract:In this study, for the first time, by employing a simple and efficient double nano-emulsification method and using sweet almond oil as the organic phase, polyethylene glycol (PEG)/graphene oxide (GO)/silk fibroin (SF) hydrogel-nanocomposite was synthesized. The aim of the research was to fabricate a biocompatible targeted pH-sensitive sustained release carrier, improve the drug loading capacity and enhance the anticancer effect of doxorubicin (DOX) drug. The obtained values for the entrapment (%EE) and loading efficacy (%LE) were 87.75 ± 0.7 % and 46 ± 1 %, respectively, and these high values were due to the use of GO with a large specific surface area and the electrostatic interaction between the drug and SF. The Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analyses confirmed the presence of all the components in the nanocomposite and the suitable interaction between them. Based on the results of dynamic light scattering analysis (DLS) and zeta potential analysis, the mean size of the carrier particles and its surface charge were 293.7 nm and -102.9 mV, respectively. The high negative charge was caused by the presence of hydroxyl groups in GO and SF and it caused proper stability of the nanocomposite. The spherical core-shell structure with its homogeneous surface was also observed in the field emission scanning electron microscopy (FE-SEM) image. The cumulative release percentage of the nanocarrier reached 95.75 after 96 h and it is higher in the acidic environment at all times. The results of fitting the release data to the kinetic models suggested that the mechanism of release was dissolution-controlled anomalous at pH 7.4 and diffusion-controlled anomalous at pH 5.4. The results of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and flow cytometry showed an increase in toxicity on MCF-7 cells and improved apoptotic cell death compared to the free drug. Consequently, the findings of this research introduced and confirmed PEG/GO/SF nanocomposite as an attractive novel drug delivery system for pH-sensitive and sustained delivery of chemotherapeutic agents in biomedicine.

A New Anti-Cancer Drug Delivery System: Polymeric Ionic Liquid Functionalized Reduced Graphene Oxide

Functional Materials From The Covalent Modification Of Reduced Graphene Oxide And Beta-Cyclodextrin As A Drug Delivery Carrier

Fabrication and Antitumor Mechanism of a Nanoparticle Drug Delivery System: Graphene Oxide/Chitosan Oligosaccharide/γ‐Polyglutamic Acid Composites for Anticancer Drug Delivery

Amphiphilic Prodrug-Decorated Graphene Oxide As a Multi-Functional Drug Delivery System for Efficient Cancer Therapy.

The Fabrication of Rgo/(pll/pasp)3 @DOX Nanorods with Ph-Switch for Photothermal Therapy and Chemotherapy.

Heparin Modified Graphene Oxide for Ph-Sensitive Sustained Release of Doxorubicin Hydrochloride.

Redox-Sensitive Prodrug Molecules Meet Graphene Oxide: an Efficient Graphene Oxide-Based Nanovehicle Toward Cancer Therapy.

Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System

Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.

Sodium Alginate Conjugated Graphene Oxide As a New Carrier for Drug Delivery System

Covalent Modification of Reduced Graphene Oxide by Means of Diazonium Chemistry and Use As a Drug-Delivery System.

Polydopamine-functionalized Nanographene Oxide: a Versatile Nanocarrier for Chemotherapy and Photothermal Therapy.

A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites

Multi-functionalized Graphene Oxide Based Anticancer Drug-Carrier with Dual-Targeting Function and Ph-Sensitivity

Mixed surfactant modified graphene oxide nanocarriers for DOX delivery to cisplatin-resistant human ovarian carcinoma cells

PEGylated Nano-Graphene Oxide As a Nanocarrier for Delivering Mixed Anticancer Drugs to Improve Anticancer Activity

Heparin-modified graphene oxide loading anti-cancer drug and growth factor with heat stability, long-term release property and lower cytotoxicity

One Step Green Reduced and Functionalized Graphene Oxide for Highly Efficient Loading and Effectively Release of Doxorubicin Hydrochloride

Multi-transformable Nanocarrier with Tumor Extracellular Acidity-Activated Charge Reversal, Size Reduction and Ligand Reemergence for in Vitro Efficient Doxorubicin Loading and Delivery

Synthesis and characterization of a novel, pH-responsive sustained release nanocarrier using polyethylene glycol, graphene oxide, and natural silk fibroin protein by a green nano emulsification method to enhance cancer treatment

Biocompatible Graphene Oxide Nanoparticle-Based Drug Delivery Platform for Tumor Microenvironment-Responsive Triggered Release of Doxorubicin